Private Equity in Behavior Analysis: Understanding the Financial Forces Reshaping ABA Service Delivery

Overview & Clinical Significance

The intersection of private equity investment and applied behavior analysis represents one of the most consequential developments in the modern history of our field. Over the past decade, the ABA service industry has undergone a dramatic transformation as venture capital and private equity firms recognized the growth trajectory of autism services, particularly following expanded insurance mandates across the United States. What was once a field dominated by small practices, university clinics, and nonprofit agencies has increasingly become a landscape shaped by consolidation, mergers, and acquisition strategies driven by financial return targets.

Cody Morris brings this topic into sharp focus by examining what private equity ownership actually means for ABA companies and the practitioners who work within them. At its core, private equity involves investment firms purchasing controlling stakes in companies with the explicit goal of increasing the company's value over a defined period, typically three to seven years, before selling the company for a profit. When this model is applied to healthcare services, including ABA, it introduces a set of incentive structures that may not always align with the clinical mission of the organization.

The rapid expansion of PE-backed ABA companies has created both opportunities and tensions within the field. On one hand, PE investment has funded geographic expansion, technology development, and increased access to services in underserved areas. On the other hand, practitioners have raised concerns about caseload expectations, clinical autonomy, and whether the pressure to generate revenue growth can coexist with individualized, high-quality treatment. These are not abstract concerns. They shape the daily experience of BCBAs making treatment decisions, RBTs delivering direct services, and families navigating a system that may prioritize throughput alongside outcomes.

For the behavior analysis community, reckoning with private equity means developing a nuanced understanding of how financial ownership structures influence organizational culture, clinical decision-making, and the sustainability of the workforce. This is not simply a business topic that practitioners can afford to ignore. The ownership model of the organization where you work directly affects your scope of practice, your caseload, the resources available to your clients, and ultimately, the quality of care delivered.

Background & Context

The growth of ABA as an industry can be traced to several converging factors. State-level autism insurance mandates, beginning with Indiana in 2001 and accelerating after 2010, created a reliable funding stream for ABA services. The prevalence of autism diagnoses continued to rise, and demand for behavioral services consistently outpaced supply. These conditions created what private equity firms recognized as a fragmented market with strong growth fundamentals, a classic target for consolidation strategies.

Private equity firms typically acquire a platform company, an established ABA provider, and then pursue a roll-up strategy by acquiring smaller practices to build scale. This approach allows the PE firm to achieve economies of scale in billing, credentialing, human resources, and technology while expanding the geographic footprint of services. The acquired companies may retain their brand names and local leadership, or they may be folded into a unified corporate structure depending on the investment thesis.

Historically, healthcare has attracted PE investment across many sectors, including dental practices, dermatology, emergency medicine staffing, and physical therapy. Research in these adjacent fields has documented both positive outcomes, such as improved administrative infrastructure, and concerning trends, such as increased patient volumes, reduced staffing ratios, and billing practices that prioritize revenue over clinical necessity. The ABA field is now experiencing its own version of this broader phenomenon.

The timeline of PE involvement in ABA is relatively compressed. Many of the largest acquisitions occurred between 2015 and 2023, during which period several ABA companies reached valuations exceeding one billion dollars. This rapid financialization caught many practitioners off guard. BCBAs who entered the field to work directly with children and families found themselves employed by organizations whose ultimate decision-makers were investment committees evaluating internal rates of return.

Understanding this context is essential because it shapes the environment in which clinical decisions are made. When an organization's primary obligation is to generate returns for investors within a defined timeline, there is inherent pressure to grow revenue. In ABA, revenue growth can come from serving more clients, increasing billable hours per client, expanding into new geographic markets, or reducing costs. Each of these levers has direct implications for clinical practice, workforce experience, and client outcomes.

Clinical Implications

The clinical implications of private equity ownership in ABA are multifaceted and warrant careful examination by every practitioner working within or alongside PE-backed organizations. The central question is whether the financial incentive structure of private equity is compatible with delivering individualized, evidence-based behavioral services.

One area of concern involves caseload management. PE-backed organizations may establish productivity expectations that require BCBAs to maintain higher caseloads than would be considered optimal for thorough assessment, treatment planning, and supervision. When a BCBA is responsible for an excessive number of clients, the quality of functional behavior assessments may decline, treatment plans may become more formulaic, and direct observation of RBT implementation may become less frequent. Each of these degradations carries real consequences for client progress.

Authorization and treatment hours represent another clinical pressure point. Organizations under financial pressure may be incentivized to recommend treatment hours that align with revenue targets rather than individual client need. While most BCBAs maintain their clinical independence in making these determinations, the organizational context in which those decisions are made is not neutral. Subtle pressures, whether through performance metrics, implicit expectations, or compensation structures tied to billable hours, can influence clinical judgment even among well-intentioned practitioners.

Staff turnover, a persistent challenge across ABA regardless of ownership structure, may be exacerbated in PE-backed settings. When cost reduction is a strategic priority, compensation and benefits for direct service providers may be constrained. High turnover among RBTs disrupts the therapeutic relationship, introduces inconsistency in treatment implementation, and places additional burden on supervising BCBAs who must repeatedly train new staff on individualized protocols.

The pace of growth itself carries clinical risks. Rapid geographic expansion requires hiring large numbers of practitioners quickly, which can strain training and quality assurance systems. New hires may begin seeing clients before they are fully acclimated to the organization's clinical model, supervision structure, or documentation standards. In a field where treatment fidelity is fundamental to outcomes, scaling too fast can erode the very quality that made the organization successful in the first place.

Conversely, PE investment has enabled some organizations to invest in clinical infrastructure that smaller practices could not afford. This includes electronic health records, data collection platforms, centralized training programs, and research departments. Access to capital can accelerate the development and implementation of tools that genuinely improve clinical practice. The challenge lies in ensuring that these investments serve clinical goals rather than primarily functioning as mechanisms to increase billing efficiency.

Ethical Considerations

The ethical dimensions of private equity in behavior analysis touch on several core principles within the Ethics Code for Behavior Analysts. Code 2.01, which addresses providing effective treatment, is perhaps the most directly relevant. This standard requires behavior analysts to prioritize client welfare and deliver services that are consistent with the best available evidence. When organizational structures create incentives that may conflict with individualized treatment, practitioners face genuine ethical tension that demands active navigation rather than passive compliance.

Code 2.14 addresses concerns around conflicts of interest and requires behavior analysts to be aware of and address situations in which personal, financial, or organizational interests could compromise their professional judgment. Working within a PE-backed organization does not automatically create a conflict of interest, but the structural incentives inherent in PE ownership models mean that practitioners must be vigilant about identifying situations where financial pressures might influence clinical recommendations.

Code 1.05 speaks to the importance of independence in professional judgment. Behavior analysts must exercise independent judgment in their clinical decision-making regardless of the organizational context in which they practice. This obligation does not change based on whether the employer is a nonprofit, a small private practice, or a PE-backed corporation. However, the nature of the pressures on that independence may differ significantly across these settings.

Code 3.01, which concerns behavior analysts' responsibility to clients, establishes that the client's interests take precedence. In the PE context, this means that if organizational directives conflict with what is in the best interest of the client, the behavior analyst has an ethical obligation to advocate for the client. This can place practitioners in difficult positions, particularly when their employment may depend on meeting organizational expectations that they believe compromise care.

There is also an organizational ethics dimension that extends beyond individual practitioner obligations. Leaders within PE-backed ABA companies bear responsibility for creating systems and cultures that support ethical practice. This includes setting reasonable caseload expectations, ensuring that performance metrics do not incentivize overauthorization, maintaining adequate supervision ratios, and protecting clinical decision-making from undue financial influence. The ethical responsibility does not rest solely on the shoulders of individual BCBAs; it is distributed throughout the organizational hierarchy.

Practitioners should also consider their ethical obligations related to transparency. Families receiving ABA services may not be aware of the ownership structure of the organization providing their child's treatment. While there is no explicit requirement to disclose PE ownership, the broader principle of honesty and transparency in the therapeutic relationship suggests that practitioners should be prepared to discuss how their organization operates when families raise questions about treatment decisions.

Assessment & Decision-Making

For behavior analysts evaluating whether to work within a PE-backed organization, or assessing whether their current organization's practices align with their professional values, a structured approach to decision-making is essential. This is not a binary question of whether PE is inherently good or bad for ABA. Rather, it requires evaluating specific organizational practices against clearly defined criteria.

Begin by examining the organization's clinical model and how it translates into day-to-day practice. What are the expected caseload sizes for BCBAs? How are treatment hours determined, and who has final authority over authorization recommendations? Is there a clinical leadership structure that operates independently from the business development and operations teams? Organizations that maintain a clear separation between clinical decision-making and financial operations are more likely to protect practitioner autonomy.

Evaluate the compensation structure and performance metrics used by the organization. If BCBA compensation is primarily tied to billable hours or revenue generation, this creates a direct financial incentive that may conflict with clinical judgment. Compensation models that include quality indicators, client outcome measures, and professional development metrics are more aligned with ethical practice.

Assess the organization's approach to staff retention and professional development. PE-backed organizations vary widely in their investment in their workforce. Some offer competitive salaries, mentorship programs, and clear career progression pathways. Others minimize labor costs as part of their financial strategy. High RBT turnover rates, low starting wages, and minimal investment in ongoing training are indicators that the organization may be prioritizing cost reduction over service quality.

Consider the organization's track record on compliance and quality assurance. Has the organization faced regulatory actions, complaints to licensing boards, or patterns of negative feedback from families? While no organization is immune to individual complaints, systemic patterns suggest structural problems that may be related to the pressures of the PE model.

Examine how the organization handles disagreements between clinical recommendations and business directives. Does the organization have a clear process for escalating concerns? Are BCBAs protected from retaliation when they advocate for client needs that may conflict with organizational revenue goals? The presence or absence of these protections reveals a great deal about the organization's commitment to ethical practice.

Finally, consider the stage of the PE investment cycle. Organizations in early growth phases may be focused on expansion and market share. Organizations nearing the end of an investment cycle, when the PE firm is preparing to sell, may face intensified pressure to maximize revenue and minimize costs. The stage of the cycle can influence the degree of financial pressure experienced at the clinical level.

What This Means for Your Practice

Whether you currently work for a PE-backed ABA company, are considering joining one, or are observing these trends from outside, the financialization of ABA services is a field-wide issue that affects every practitioner. Cody Morris frames this topic as a reckoning, and that framing is appropriate because it demands that the behavior analysis community collectively determine what it values and how it will protect those values in the face of powerful economic forces.

If you are employed by a PE-backed organization, your most important responsibility is maintaining the integrity of your clinical judgment. Document your clinical rationale thoroughly. When you encounter organizational expectations that conflict with your professional assessment of client need, use the organization's formal channels to raise concerns. Connect with other BCBAs in your organization to identify shared concerns and develop collective approaches to advocacy.

If you are in a leadership position, recognize that your decisions about caseload expectations, performance metrics, and resource allocation directly shape the ethical environment for every practitioner in your organization. Building systems that protect clinical autonomy is not merely a nice-to-have; it is a professional obligation.

For the field broadly, this topic underscores the importance of behavior analysts understanding the business and financial contexts in which they practice. Graduate programs in behavior analysis rarely cover organizational economics, corporate governance, or the mechanics of private equity. Yet these factors shape clinical practice in profound ways. Advocating for the inclusion of these topics in professional training is a tangible step toward better-prepared practitioners.

The PE reckoning in ABA is ultimately about whether the field can maintain its clinical and ethical commitments while operating within financial structures that were designed for a different purpose. The answer depends on practitioners who understand both the opportunities and the risks, and who refuse to cede clinical judgment to financial imperatives.